{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T18:21:43Z","timestamp":1792261303136,"version":"4.4.0"},"reference-count":243,"publisher":"American Society for Clinical Investigation","issue":"4","license":[{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,16]]},"abstract":"<jats:p>Glucagon-like peptide-1 receptor agonists (GLP-1RAs), established therapies for type 2 diabetes and obesity, are increasingly recognized for their potential in neurodegenerative diseases. Preclinical studies across diverse neurodegenerative conditions consistently demonstrate neuroprotective effects of GLP-1RAs, including reduced protein aggregation, enhanced autophagy, improved mitochondrial function, suppression of neuroinflammation, and preservation of synaptic integrity. Epidemiological analyses further suggest reduced incidence of dementia, Parkinson disease, and multiple sclerosis among long-term GLP-1RA users. Early human trials provide signals of target engagement, such as preserved cerebral glucose metabolism, altered inflammatory biomarkers, and slowed brain atrophy, although clinical outcomes to date remain mixed and trials in rarer disorders are sparse. Translation is constrained by uncertainty around optimal molecule choice, CNS penetrance, tolerability, adherence, and heterogeneity of response. Furthermore, next-generation dual and triple agonists may offer enhanced efficacy but remain untested in neurodegeneration. Conceptually, GLP-1RAs share pleiotropic effects with exercise \u2014 one of the few interventions with proven disease-modifying potential \u2014 by enhancing insulin signaling, stabilizing mitochondria, reducing inflammation, and promoting synaptic plasticity. This overlap highlights their promise as \u201cpharmacological analogues of exercise,\u201d and underscores the need for biomarker-driven, disease-specific trials to establish whether GLP-1RAs can deliver durable disease modification across the spectrum of neurodegenerative diseases.<\/jats:p>","DOI":"10.1172\/jci194745","type":"journal-article","created":{"date-parts":[[2026,2,15]],"date-time":"2026-02-15T19:00:58Z","timestamp":1771182058000},"source":"Crossref","is-referenced-by-count":25,"title":["The promise of GLP-1 receptor agonists for neurodegenerative diseases"],"prefix":"10.1172","volume":"136","author":[{"given":"Dilan","family":"Athauda","sequence":"first","affiliation":[{"name":"The Francis Crick Institute, London, United Kingdom."},{"name":"Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel H.","family":"Greig","sequence":"additional","affiliation":[{"name":"Drug Design and Development Section, Translational Gerontology Branch, Intramural Research Program, National Institute on Aging, NIH, Baltimore, Maryland, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2172-7527","authenticated-orcid":true,"given":"Wassilios G.","family":"Meissner","sequence":"additional","affiliation":[{"name":"CHU Bordeaux, Service de Neurologie des Maladies Neurod\u00e9g\u00e9n\u00e9ratives, IMNc, Bordeaux, France."},{"name":"University de Bordeaux, CNRS, IMN, UMR 5293, Bordeaux, France."},{"name":"Department of Medicine, University of Otago, Christchurch, and New Zealand Brain Research Institute, Christchurch, New Zealand."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Foltynie","sequence":"additional","affiliation":[{"name":"Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Gandhi","sequence":"additional","affiliation":[{"name":"The Francis Crick Institute, London, United Kingdom."},{"name":"Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"232","published-online":{"date-parts":[[2026,2,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2024-080952"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-004-0552-1"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10040778"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000002461"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1111\/ane.12793"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-023-00462-8"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.je.2016.06.006"},{"issue":"6","key":"B8","article-title":"Exploring the role of diabetes in ALS: a population-based cohort study","volume":"15","author":"Martinelli","year":"2025","journal-title":"Life (Basel)"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.3007"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-06463-6"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1080\/21678421.2025.2515913"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26168078"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.2337\/db14-1507"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000005475"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/mds.29122"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02221-9"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2019.00788"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awx256"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2019.00801"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2019.00017"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2019.01.008"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.687157"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2023.101999"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/alz.047353"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2015.03.006"},{"key":"B26","doi-asserted-by":"crossref","unstructured":"Athauda D, et al. GLP1 receptor agonism ameliorates Parkinson\u2019s disease through modulation of neuronal insulin signalling and glial suppression [preprint]. https:\/\/doi.org\/10.1101\/2024.02.28.582460 Posted on bioRxiv February 28, 2024","DOI":"10.1101\/2024.02.28.582460"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26094209"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252313169"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24043506"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.4103\/NRR.NRR-D-23-01910"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1096\/fj.06-7703com"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.22-10-j0001.2002"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2023.09.005"},{"issue":"suppl 2","key":"B34","article-title":"Brain insulin resistance in Parkinson\u2019s disease","volume":"32","author":"Bassil","year":"2017","journal-title":"Mov Disord"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1172\/JCI59903"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-014-1328-5"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awx044"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2018.08.023"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.acra.2015.07.014"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2014.10.008"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2010.225"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1006\/nbdi.2002.0562"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-016-3445-y"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1007\/s11011-024-01347-2"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.2337\/dbi18-0045"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurot.2025.e00712"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2004.02914.x"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2016.01.013"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2022.970925"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2025.107770"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2024-335593"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-022-01792-4"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23179583"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2019.01.103"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.13248"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1002\/path.5056"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3233\/JPD-181503"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.2337\/db08-0799"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0032008"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31585-4"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)02808-3"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.2174\/1567205016666190913155950"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-023-00676-7"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.121.263194"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2018.00002"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23179655"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2025.112629"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2017.00443"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-26949-6"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1186\/s10020-024-00817-8"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-06307-7"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2021.101180"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17718-y"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2016.00108"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.7150\/thno.15993"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18091861"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2020.05.001"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.68974"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.4103\/1673-5374.389626"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1111\/febs.16151"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20071584"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-025-01275-w"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-022-00956-6"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-06373-1"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-023-00672-x"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1677\/JOE-09-0132"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2016.00433"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-024-01573-x"},{"issue":"2","key":"B89","first-page":"1219","article-title":"Comparison between the effects of sitagliptin and liraglutide on blood glucose and cognitive function of patients with both type 2 diabetes mellitus and post-stroke mild cognitive impairment","volume":"13","author":"Wang","year":"2020","journal-title":"Int J Clin Exp Med"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e18491"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1033479"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01931-z"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.3390\/ph18050614"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-2010-1314"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1002\/alz.038285"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-87809-4"},{"key":"B97","unstructured":"Alzheimer\u2019s Association. Research Advances at the Alzheimer\u2019s Association International Conference. https:\/\/aaic.alz.org\/releases-2024\/highlights-aaic-2024.asp Published August 1, 2024. Accessed August 30, 2025"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01743-1"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2024.1481390"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1282431"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2025.101982"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1016\/j.mib.2024.102473"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1016\/j.tma.2025.02.001"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2020.10.014"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms10102061"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1177\/1535370217743765"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.5662\/wjm.v12.i4.246"},{"issue":"47","key":"B108","article-title":"Differences in gut microbiota modulation by semaglutide, liraglutide and tirzepatide","volume":"23","author":"Nowakowska","year":"2025","journal-title":"Int J Innov Technol Soc Sci"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.997578"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-023-02184-y"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.EJ23-0723"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-130584"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2016.3742"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2016.04.052"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1016\/j.physbeh.2016.03.016"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2012.04.009"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2019.04.006"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2014.02.022"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.10611"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.102.037481"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2019.111932"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2017.11.048"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2025.177305"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1177\/13872877251329439"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0529-11.2011"},{"key":"B126","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.neuropharm.2013.08.005","article-title":"Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP\/PS1 mice, a model of Alzheimer\u2019s disease","volume":"76 Pt A","author":"McClean","year":"2014","journal-title":"Neuropharmacology"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2021.111529"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1007\/s12031-019-1257-9"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2015.07.024"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0158205"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1007\/s11064-017-2250-8"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1172\/JCI57256"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-190237"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117540"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2024.102019"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e39157"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2025.0360"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000208642"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-03355-2"},{"key":"B140","article-title":"Liraglutide in mild to moderate Alzheimer\u2019s disease: a phase 2b clinical trial","author":"Edison","journal-title":"Nat Med"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-024-01666-7"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.21483"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2009.00486.x"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0806720106"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjms.2017.05.002"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2015.06.054"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-017-0331-6"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1016\/j.npep.2018.07.003"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-021-01180-z"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1021\/acsptsci.1c00013"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-024-01025-6"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awaa262"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1002\/mds.29992"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1172\/JCI68295"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.3233\/JPD-140364"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31585-4"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2018.4304"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(23)00378-2"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2312323"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.98.18_supplement.3068"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1007\/s12640-019-9998-3"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24054687"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.3233\/JPD-240002"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-022-01103-7"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1002\/ana.70004"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27123878"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0036857"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-96418-0"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25105059"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000208998"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2020.1728096"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19092505"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.731483"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M112.387316"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.950623"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.4103\/1673-5374.205105"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22062971"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/276186"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2006.09.028"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.2337\/db25-0158"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-023-01390-4"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-017-0550-2"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241311162"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0082016"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106715"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2019.113113"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2015.07.489"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2012.10.001"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.1111\/cns.14308"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.1021\/acsptsci.9b00003"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.1159\/000529438"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awad003"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aan0972"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.3390\/ph17101313"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1007980"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.121.038151"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.121.037775"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-025-01423-9"},{"key":"B199","article-title":"Efficacy of glucagon-like peptide-1 receptor agonists for prevention of stroke among patients with and without diabetes: a meta-analysis with the SELECT and FLOW trails","volume":"57","author":"Gera","year":"2025","journal-title":"Int J Cardiol Heart Vasc"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-022-01686-3"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.1177\/02537176241246744"},{"key":"B202","doi-asserted-by":"publisher","DOI":"10.1176\/appi.neuropsych.20230226"},{"key":"B203","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-025-06914-0"},{"key":"B204","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2025.0679"},{"key":"B205","doi-asserted-by":"publisher","DOI":"10.1016\/j.numecd.2025.104213"},{"key":"B206","doi-asserted-by":"publisher","DOI":"10.1007\/s13679-025-00623-1"},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102782"},{"key":"B208","doi-asserted-by":"publisher","DOI":"10.1097\/WNR.0000000000000548"},{"key":"B209","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2017.10.012"},{"key":"B210","doi-asserted-by":"publisher","DOI":"10.3390\/biom14070872"},{"key":"B211","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2022.101533"},{"key":"B212","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2025.102118"},{"key":"B213","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2024.109952"},{"key":"B214","doi-asserted-by":"publisher","DOI":"10.1080\/21688370.2023.2292461"},{"key":"B215","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2020.114187"},{"key":"B216","doi-asserted-by":"publisher","DOI":"10.1038\/ijo.2015.136"},{"key":"B217","doi-asserted-by":"crossref","unstructured":"Hogg E, et al. A phase II, randomized, double-blinded, placebo-controlled trial of liraglutide in Parkinson\u2019s disease [preprint]. https:\/\/doi.org\/10.2139\/ssrn.4212371 Posted on Lancet September 12, 2022","DOI":"10.2139\/ssrn.4212371"},{"key":"B218","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2023.11.009"},{"key":"B219","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.116.012934"},{"key":"B220","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2021.750726"},{"key":"B221","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.57349"},{"key":"B222","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2024-089477"},{"key":"B223","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2024.100853"},{"key":"B224","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-024-01798-9"},{"key":"B225","doi-asserted-by":"publisher","DOI":"10.3390\/jpm12030424"},{"key":"B226","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2025.2517802"},{"key":"B227","doi-asserted-by":"publisher","DOI":"10.3233\/JPD-181329"},{"key":"B228","doi-asserted-by":"publisher","DOI":"10.1249\/ESM.0000000000000019"},{"key":"B229","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2021.101543"},{"key":"B230","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2025.1502417"},{"key":"B231","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1205207"},{"key":"B232","doi-asserted-by":"publisher","DOI":"10.3390\/receptors4010002"},{"key":"B233","doi-asserted-by":"publisher","DOI":"10.3233\/ADR-230181"},{"key":"B234","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25073812"},{"key":"B235","doi-asserted-by":"publisher","DOI":"10.1186\/s13098-025-01888-1"},{"key":"B236","article-title":"The effect of GLP-1 receptor agonists in pre-clinical rodent models of Parkinson\u2019s disease: a systematic review and meta-analysis","volume":"6","author":"Dahiya","year":"2022","journal-title":"Clin Park Relat Disord"},{"key":"B237","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-025-03932-3"},{"key":"B238","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-019-00805-5"},{"key":"B239","doi-asserted-by":"publisher","DOI":"10.1080\/13543784.2025.2587277"},{"key":"B240","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2024.106229"},{"key":"B241","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.844697"},{"issue":"3","key":"B242","article-title":"Efficacy of GLP-1 agonists in psychiatric illnesses: a scoping review","volume":"27","author":"Ali","year":"2025","journal-title":"Prim Care Companion CNS Disord"},{"key":"B243","doi-asserted-by":"publisher","DOI":"10.1111\/dom.70198"}],"container-title":["Journal of Clinical Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jci.org\/articles\/view\/194745\/files\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T16:45:08Z","timestamp":1779209108000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jci.org\/articles\/view\/194745"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,16]]},"references-count":243,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,2,16]]},"published-print":{"date-parts":[[2026,2,16]]}},"alternative-id":["10.1172\/JCI194745"],"URL":"https:\/\/doi.org\/10.1172\/jci194745","relation":{},"ISSN":["1558-8238"],"issn-type":[{"value":"1558-8238","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,16]]},"article-number":"e194745"}}